Robert Bell

Partner Innosight (Huron)

Last Reviewed: September 18, 2026

Executive Summary

Robert (“Rob”) Bell is a Partner at Innosight, the strategy and innovation consulting business that operates as part of Huron Consulting Group. Over roughly six years and 22 client projects he co-led the firm’s Industrial and MedTech practices, advising leadership teams on growth strategy and disruptive innovation across an unusually wide industrial span — equipment, agriculture, mining, construction, steel, energy, chemicals, water, telecommunications, insurance, software, and healthcare. Innosight’s particular position in consulting derives from the disruption theory associated with its co-founder Clayton Christensen, and Bell’s work has applied that lens to the transitions facing industrial and medical technology firms: principally the shift from selling products to selling outcomes.

Career Highlights

• Co-led Innosight’s Industrial and MedTech practices across a six-year, 22-project tenure.
• Co-authored “Transforming Medtech: Strategies for Shifting from Devices to Digital Healthcare Solutions” (October 2024).
• Co-authored “Products to Solutions: Three Keys for Industrial Companies to Make the Switch” (April 2024).
• Co-authored “Innovation Within Reach: Balancing Growth and Cost Discipline in Times of Uncertainty” (May 2024).
• Former Partner at Treacy & Company and Principal at Cambridge Strategic Management Group, with earlier roles at Adventis and Monitor Group.
• Holds four degrees, from Dartmouth, Georgetown (two), and George Washington University.

Professional Journey

Bell accumulated an unusually broad academic foundation before entering consulting: a BA in Economics from Dartmouth College, then both an MA in Economics and a Master of Science in Foreign Service with honors in International Business from Georgetown University, and an MBA in Finance from George Washington University. The combination of economics, international affairs, and finance maps onto the kind of work he went on to do, which routinely involves reasoning about how industries restructure rather than about single firms.

He spent roughly two decades in strategy consulting before Innosight, with earlier roles at Monitor Group and Adventis, a principal position at Cambridge Strategic Management Group where he focused on helping organizations extract value from their data and manage significant change, and partner rank at Treacy & Company, a growth and innovation consulting firm.

At Innosight he co-led the Industrial and MedTech practices, two sectors facing structurally similar problems despite their surface differences. Industrial manufacturers built their economics on selling capital equipment, but customers increasingly want uptime, throughput, or a guaranteed outcome rather than a machine — which requires a manufacturer to rebuild its commercial model, its service organization, and its data capabilities simultaneously. Medical technology companies face the same pressure in a more regulated form, as devices become nodes in digital healthcare systems and payers reward outcomes rather than units shipped. Bell’s published work addresses both transitions directly, in “Products to Solutions: Three Keys for Industrial Companies to Make the Switch” and “Transforming Medtech: Strategies for Shifting from Devices to Digital Healthcare Solutions,” both published in 2024, alongside “Innovation Within Reach,” which took up how companies sustain innovation investment under cost pressure.

He appeared frequently in Innosight’s public webcasts and client discussions, often alongside colleague Ned Calder, on navigating disruption in industrial and healthcare markets.

Education

George Washington University

MBA, Finance

Georgetown University

MSFS, Foreign Service, honors in International Business

Georgetown University

MA, Economics

Dartmouth College

BA, Economics